abstract PURPOSE. The relationship between plasma homocysteine and stroke is controversial in many studies. There are only a few serial-sample studies which have looked at changes in stroke homocysteine during acute stroke. None of these studies investigated the changes in homocysteine in the first 3 days after stroke onset. Therefore, we designed this serial-sample prospective study to elucidate patterns of homocysteine concentration fluctuation at 0, 24 and 48 hours post stroke. MATERIAL AND METHODS. Thirty one (22 ischemic and 9 hemorrhagic) patients with stroke and thirty three controls were selected. Three homocysteine levels were obtained from all stroke patients, while only one sample was taken from controls. RESULTS. Plasma homocysteine concentration was higher in males and in hemorrhagic stroke patients at all time points. Paired sample testing revealed significant differences in the mean values of homocysteine taken at 48 hours (p=0.047, 95% CI: -1.467 to -0.011) for all cases. For patients with hemorrhagic stroke, significant values were again obtained at 48 hours only (p=0.024, 95% CI:-8.266 to -0.763). After gender stratification, we found significantly higher mean homocysteine concentrations at all time points in male patients (at 0 hour: p=0.043, 95%CI: -5.197 to -0.908; after 24 hours: p=0.002, 95%CI: -7.899 to -2.279; after 48 hours: p=0.032, 95%CI: -4.644 to -0.246). CONCLUSIONS. In this pilot study, we found that, on average, homocysteine levels initially decrease and then gradually rise in stroke patients, especially patients with hemorrhagic stroke. Also, there are significant genderbased differences in plasma homocysteine levels in our study population. In addition to increased levels of homocysteine after 48 hours in stroke patients, we found moderate hyperhomocysteinemia in our healthy controls, consistent with previous data from Pakistan.
introduction
Stroke is a major cause of morbidity and mortality worldwide [1] . The past three decades have seen the burden of stroke to rise in South Asian countries (including Pakistan) [2] . One of the main foci for stroke related research is preventable risk factors.
Conventional risk factors for stroke are hypertension, smoking, diabetes mellitus, obesity, and family history). Increased blood homocysteine, hyperhomocysteinemia, has been cited as a possible new risk factor for various neurodegenerative conditions, including stroke [3] . Various experiments have shown homocysteine to cause vascular injury, which may contribute to the development of cardio-and cerebrovascular diseases via various mechanisms [4, 5] .
However, the correlation between homocysteine levels and risk of stroke is still controversial [6] [7] [8] [9] [10] [11] . The risk of ischemic stroke associated with an elevated homocysteine level has been found to be significantly weaker in prospective studies than in retrospective studies, which may reflect difficulties in selecting controls or the effect of changes in treatment, or other factors after stroke onset [12] . Furthermore, results of many large prospective trials have shown no benefit of the prophylactic use of folic acid and vitamin B12 in patients with established vascular disease and mild hyperhomocysteinemia [12] [13] [14] .
In this pilot study, we wanted to investigate how homocysteine levels change during the acute phase of stroke. We therefore designed this study to compare serial homocysteine levels in acute stroke along a timeline of 0, 24 and 48 hours from onset of stroke. 
Statistical analysis
All analyses were performed using SPSS for 
results

Clinical characteristics of the study
Refer to Table 1 .
General homocysteine concentration results
Mean homocysteine values in all stroke and control participants were found to be in moderate hyperhomocysteinemic range i.e. between 15-30 micromoles/liter. Plasma homocysteine concentration was higher in males than females, and higher in hemorrhagic than ischemic stroke participants at all time points (Table 2) 
Serial homocysteine concentration results
Paired sample testing revealed significant differences in mean values of homocysteine between 24 and 48 hours (p=0.047, see Table 3 for details) for all cases. 
Gender stratification results
After data stratification for gender, we found significant differences between mean homocysteine concentrations at all time points in male stroke cases (Table 5) .
Homocysteine data for females did not show any significant results. There were no gender differences when mean homocysteine concentrations were compared between cases and controls.
Linear regression results
Regression analysis showed that age and traditional stroke risk factors such as gender, hypertension, heart disease, diabetes, and smoking did not affect homocysteine levels.
Discussion
Our key findings in this study are: Other possible explanation could be increased production of acute phase proteins [18] .
Moreover, male stroke participants showed significant differences in mean homocysteine levels at all time points, indicating the importance of gender in stroke-homocysteine relationship. We cannot elaborate on this point further because of our small sample size, limited homocysteine related data available from this part of Asia, and the scarcity of published data on serial homocysteine levels in stroke (especially prospective studies).
Hyperhomocysteinemia has been found to be common in normal populations of South Asia including Pakistan (Southern parts mostly) [19] [20] [21] . In addition to stroke participants, our healthy control participants also showed moderate hyperhomocysteinemia. Our study population was in Northern Pakistan while the published literature on hyperhomocysteinemic controls is related to Southern parts of the country (the two parts differ ethnically and culturally). A recent meta-analysis also describes a genetic variant conferring higher plasma homocysteine levels in Asian communities than in other parts of the world [22] . Therefore, the initial decrease in plasma homocysteine in stroke cases described in our results also becomes clinically important in this context.
There is conflicting evidence about the relationship of homocysteine and hemorrhagic stroke with some studies finding raised homocysteine levels in hemorrhagic stroke [23, 24] , others reporting the same in ischemic stroke [25] , and still others finding raised homocysteine in both stroke subtypes [26] . Our finding of raised homocysteine concentrations in hemorrhagic stroke cases adds to the homocysteine-hemorrhagic stroke linkage.
This may represent specific pathophysiological, especially genetic, differences between the two subtypes.
In addition to the sample size, the most serious limitation of this study is the lack of data on immune activation. Concurrent detailed leucocyte differential data would have helped us to understand the seemingly linked roles of immune activation and homocysteine.
Concurrent plasma vitamin B12 and folate levels could not be attained due to financial constraints, though they would have helped to clarify the results further. It is for these reasons that these results may not be extrapolated more generically.
In conclusion, further work is needed to elucidate the importance of homocysteine changes in stroke patients, as well as to reveal reliable normative homocysteine reference data in the Pakistani population.
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